Home   Package List   Routine Alphabetical List   Global Alphabetical List   FileMan Files List   FileMan Sub-Files List   Package Component Lists   Package-Namespace Mapping  
Routine: IBDEI00U

IBDEI00U.m

Go to the documentation of this file.
IBDEI00U ; ; 01-FEB-2021
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2021
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1039,1,4,0)
 ;;=4^C81.32
 ;;^UTILITY(U,$J,358.3,1039,2)
 ;;=^5001423
 ;;^UTILITY(U,$J,358.3,1040,0)
 ;;=C81.33^^19^113^258
 ;;^UTILITY(U,$J,358.3,1040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1040,1,3,0)
 ;;=3^Lymphocyte Depleted Classical Hodgkin Lymphoma,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,1040,1,4,0)
 ;;=4^C81.33
 ;;^UTILITY(U,$J,358.3,1040,2)
 ;;=^5001424
 ;;^UTILITY(U,$J,358.3,1041,0)
 ;;=C81.34^^19^113^259
 ;;^UTILITY(U,$J,358.3,1041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1041,1,3,0)
 ;;=3^Lymphocyte Depleted Classical Hodgkin Lymphoma,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,1041,1,4,0)
 ;;=4^C81.34
 ;;^UTILITY(U,$J,358.3,1041,2)
 ;;=^5001425
 ;;^UTILITY(U,$J,358.3,1042,0)
 ;;=C81.35^^19^113^260
 ;;^UTILITY(U,$J,358.3,1042,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1042,1,3,0)
 ;;=3^Lymphocyte Depleted Classical Hodgkin Lymphoma,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,1042,1,4,0)
 ;;=4^C81.35
 ;;^UTILITY(U,$J,358.3,1042,2)
 ;;=^5001426
 ;;^UTILITY(U,$J,358.3,1043,0)
 ;;=C81.36^^19^113^261
 ;;^UTILITY(U,$J,358.3,1043,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1043,1,3,0)
 ;;=3^Lymphocyte Depleted Classical Hodgkin Lymphoma,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,1043,1,4,0)
 ;;=4^C81.36
 ;;^UTILITY(U,$J,358.3,1043,2)
 ;;=^5001427
 ;;^UTILITY(U,$J,358.3,1044,0)
 ;;=C81.37^^19^113^262
 ;;^UTILITY(U,$J,358.3,1044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1044,1,3,0)
 ;;=3^Lymphocyte Depleted Classical Hodgkin Lymphoma,Spleen
 ;;^UTILITY(U,$J,358.3,1044,1,4,0)
 ;;=4^C81.37
 ;;^UTILITY(U,$J,358.3,1044,2)
 ;;=^5001428
 ;;^UTILITY(U,$J,358.3,1045,0)
 ;;=C81.38^^19^113^263
 ;;^UTILITY(U,$J,358.3,1045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1045,1,3,0)
 ;;=3^Lymphocyte Depleted Classical Hodgkin Lymphoma,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,1045,1,4,0)
 ;;=4^C81.38
 ;;^UTILITY(U,$J,358.3,1045,2)
 ;;=^5001429
 ;;^UTILITY(U,$J,358.3,1046,0)
 ;;=C81.39^^19^113^264
 ;;^UTILITY(U,$J,358.3,1046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1046,1,3,0)
 ;;=3^Lymphocyte Depleted Classical Hodgkin Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,1046,1,4,0)
 ;;=4^C81.39
 ;;^UTILITY(U,$J,358.3,1046,2)
 ;;=^5001430
 ;;^UTILITY(U,$J,358.3,1047,0)
 ;;=C81.40^^19^113^265
 ;;^UTILITY(U,$J,358.3,1047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1047,1,3,0)
 ;;=3^Lymphocyte-Rich Classical Hodgkin Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,1047,1,4,0)
 ;;=4^C81.40
 ;;^UTILITY(U,$J,358.3,1047,2)
 ;;=^5001431
 ;;^UTILITY(U,$J,358.3,1048,0)
 ;;=C81.41^^19^113^266
 ;;^UTILITY(U,$J,358.3,1048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1048,1,3,0)
 ;;=3^Lymphocyte-Rich Classical Hodgkin Lymphoma,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,1048,1,4,0)
 ;;=4^C81.41
 ;;^UTILITY(U,$J,358.3,1048,2)
 ;;=^5001432
 ;;^UTILITY(U,$J,358.3,1049,0)
 ;;=C81.42^^19^113^267
 ;;^UTILITY(U,$J,358.3,1049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1049,1,3,0)
 ;;=3^Lymphocyte-Rich Classical Hodgkin Lymphoma,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,1049,1,4,0)
 ;;=4^C81.42
 ;;^UTILITY(U,$J,358.3,1049,2)
 ;;=^5001433
 ;;^UTILITY(U,$J,358.3,1050,0)
 ;;=C81.43^^19^113^268
 ;;^UTILITY(U,$J,358.3,1050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1050,1,3,0)
 ;;=3^Lymphocyte-Rich Classical Hodgkin Lymphoma,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,1050,1,4,0)
 ;;=4^C81.43
 ;;^UTILITY(U,$J,358.3,1050,2)
 ;;=^5001434
 ;;^UTILITY(U,$J,358.3,1051,0)
 ;;=C81.44^^19^113^269
 ;;^UTILITY(U,$J,358.3,1051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1051,1,3,0)
 ;;=3^Lymphocyte-Rich Classical Hodgkin Lymphoma,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,1051,1,4,0)
 ;;=4^C81.44
 ;;^UTILITY(U,$J,358.3,1051,2)
 ;;=^5001435
 ;;^UTILITY(U,$J,358.3,1052,0)
 ;;=C81.45^^19^113^270
 ;;^UTILITY(U,$J,358.3,1052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1052,1,3,0)
 ;;=3^Lymphocyte-Rich Classical Hodgkin Lymphoma,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,1052,1,4,0)
 ;;=4^C81.45
 ;;^UTILITY(U,$J,358.3,1052,2)
 ;;=^5001436
 ;;^UTILITY(U,$J,358.3,1053,0)
 ;;=C81.46^^19^113^271
 ;;^UTILITY(U,$J,358.3,1053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1053,1,3,0)
 ;;=3^Lymphocyte-Rich Classical Hodgkin Lymphoma,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,1053,1,4,0)
 ;;=4^C81.46
 ;;^UTILITY(U,$J,358.3,1053,2)
 ;;=^5001437
 ;;^UTILITY(U,$J,358.3,1054,0)
 ;;=C81.47^^19^113^272
 ;;^UTILITY(U,$J,358.3,1054,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1054,1,3,0)
 ;;=3^Lymphocyte-Rich Classical Hodgkin Lymphoma,Spleen
 ;;^UTILITY(U,$J,358.3,1054,1,4,0)
 ;;=4^C81.47
 ;;^UTILITY(U,$J,358.3,1054,2)
 ;;=^5001438
 ;;^UTILITY(U,$J,358.3,1055,0)
 ;;=C81.48^^19^113^273
 ;;^UTILITY(U,$J,358.3,1055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1055,1,3,0)
 ;;=3^Lymphocyte-Rich Classical Hodgkin Lymphoma,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,1055,1,4,0)
 ;;=4^C81.48
 ;;^UTILITY(U,$J,358.3,1055,2)
 ;;=^5001439
 ;;^UTILITY(U,$J,358.3,1056,0)
 ;;=C81.49^^19^113^274
 ;;^UTILITY(U,$J,358.3,1056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1056,1,3,0)
 ;;=3^Lymphocyte-Rich Classical Hodgkin Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,1056,1,4,0)
 ;;=4^C81.49
 ;;^UTILITY(U,$J,358.3,1056,2)
 ;;=^5001440
 ;;^UTILITY(U,$J,358.3,1057,0)
 ;;=C81.70^^19^113^233
 ;;^UTILITY(U,$J,358.3,1057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1057,1,3,0)
 ;;=3^Hodgkin Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,1057,1,4,0)
 ;;=4^C81.70
 ;;^UTILITY(U,$J,358.3,1057,2)
 ;;=^5001441
 ;;^UTILITY(U,$J,358.3,1058,0)
 ;;=C81.71^^19^113^219
 ;;^UTILITY(U,$J,358.3,1058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1058,1,3,0)
 ;;=3^Hodgkin Lymphoma,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,1058,1,4,0)
 ;;=4^C81.71
 ;;^UTILITY(U,$J,358.3,1058,2)
 ;;=^5001442
 ;;^UTILITY(U,$J,358.3,1059,0)
 ;;=C81.72^^19^113^227
 ;;^UTILITY(U,$J,358.3,1059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1059,1,3,0)
 ;;=3^Hodgkin Lymphoma,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,1059,1,4,0)
 ;;=4^C81.72
 ;;^UTILITY(U,$J,358.3,1059,2)
 ;;=^5001443
 ;;^UTILITY(U,$J,358.3,1060,0)
 ;;=C81.73^^19^113^223
 ;;^UTILITY(U,$J,358.3,1060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1060,1,3,0)
 ;;=3^Hodgkin Lymphoma,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,1060,1,4,0)
 ;;=4^C81.73
 ;;^UTILITY(U,$J,358.3,1060,2)
 ;;=^5001444
 ;;^UTILITY(U,$J,358.3,1061,0)
 ;;=C81.74^^19^113^215
 ;;^UTILITY(U,$J,358.3,1061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1061,1,3,0)
 ;;=3^Hodgkin Lymphoma,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,1061,1,4,0)
 ;;=4^C81.74
 ;;^UTILITY(U,$J,358.3,1061,2)
 ;;=^5001445
 ;;^UTILITY(U,$J,358.3,1062,0)
 ;;=C81.75^^19^113^221
 ;;^UTILITY(U,$J,358.3,1062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1062,1,3,0)
 ;;=3^Hodgkin Lymphoma,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,1062,1,4,0)
 ;;=4^C81.75
 ;;^UTILITY(U,$J,358.3,1062,2)
 ;;=^5001446
 ;;^UTILITY(U,$J,358.3,1063,0)
 ;;=C81.76^^19^113^225
 ;;^UTILITY(U,$J,358.3,1063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1063,1,3,0)
 ;;=3^Hodgkin Lymphoma,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,1063,1,4,0)
 ;;=4^C81.76
 ;;^UTILITY(U,$J,358.3,1063,2)
 ;;=^5001447
 ;;^UTILITY(U,$J,358.3,1064,0)
 ;;=C81.77^^19^113^231
 ;;^UTILITY(U,$J,358.3,1064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1064,1,3,0)
 ;;=3^Hodgkin Lymphoma,Spleen
 ;;^UTILITY(U,$J,358.3,1064,1,4,0)
 ;;=4^C81.77
 ;;^UTILITY(U,$J,358.3,1064,2)
 ;;=^5001448
 ;;^UTILITY(U,$J,358.3,1065,0)
 ;;=C81.78^^19^113^229
 ;;^UTILITY(U,$J,358.3,1065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1065,1,3,0)
 ;;=3^Hodgkin Lymphoma,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,1065,1,4,0)
 ;;=4^C81.78
 ;;^UTILITY(U,$J,358.3,1065,2)
 ;;=^5001449
 ;;^UTILITY(U,$J,358.3,1066,0)
 ;;=C81.79^^19^113^217
 ;;^UTILITY(U,$J,358.3,1066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1066,1,3,0)
 ;;=3^Hodgkin Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,1066,1,4,0)
 ;;=4^C81.79
 ;;^UTILITY(U,$J,358.3,1066,2)
 ;;=^5001450
 ;;^UTILITY(U,$J,358.3,1067,0)
 ;;=C81.90^^19^113^234
 ;;^UTILITY(U,$J,358.3,1067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1067,1,3,0)
 ;;=3^Hodgkin Lymphoma,Unspec,Unspec Site
 ;;^UTILITY(U,$J,358.3,1067,1,4,0)
 ;;=4^C81.90
 ;;^UTILITY(U,$J,358.3,1067,2)
 ;;=^5001451
 ;;^UTILITY(U,$J,358.3,1068,0)
 ;;=C81.91^^19^113^220
 ;;^UTILITY(U,$J,358.3,1068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1068,1,3,0)
 ;;=3^Hodgkin Lymphoma,Head/Face/Neck Nodes,Unspec
 ;;^UTILITY(U,$J,358.3,1068,1,4,0)
 ;;=4^C81.91
 ;;^UTILITY(U,$J,358.3,1068,2)
 ;;=^5001452
 ;;^UTILITY(U,$J,358.3,1069,0)
 ;;=C81.92^^19^113^228
 ;;^UTILITY(U,$J,358.3,1069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1069,1,3,0)
 ;;=3^Hodgkin Lymphoma,Intrathoracic Nodes,Unspec
 ;;^UTILITY(U,$J,358.3,1069,1,4,0)
 ;;=4^C81.92
 ;;^UTILITY(U,$J,358.3,1069,2)
 ;;=^5001453
 ;;^UTILITY(U,$J,358.3,1070,0)
 ;;=C81.93^^19^113^224
 ;;^UTILITY(U,$J,358.3,1070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1070,1,3,0)
 ;;=3^Hodgkin Lymphoma,Intra-Abdominal Nodes,Unspec
 ;;^UTILITY(U,$J,358.3,1070,1,4,0)
 ;;=4^C81.93
 ;;^UTILITY(U,$J,358.3,1070,2)
 ;;=^5001454
 ;;^UTILITY(U,$J,358.3,1071,0)
 ;;=C81.94^^19^113^216
 ;;^UTILITY(U,$J,358.3,1071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1071,1,3,0)
 ;;=3^Hodgkin Lymphoma,Axilla/Upper Limb Nodes,Unspec
 ;;^UTILITY(U,$J,358.3,1071,1,4,0)
 ;;=4^C81.94
 ;;^UTILITY(U,$J,358.3,1071,2)
 ;;=^5001455
 ;;^UTILITY(U,$J,358.3,1072,0)
 ;;=C81.95^^19^113^222
 ;;^UTILITY(U,$J,358.3,1072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1072,1,3,0)
 ;;=3^Hodgkin Lymphoma,Ing Region/Lower Limb Nodes,Unspec
 ;;^UTILITY(U,$J,358.3,1072,1,4,0)
 ;;=4^C81.95
 ;;^UTILITY(U,$J,358.3,1072,2)
 ;;=^5001456
 ;;^UTILITY(U,$J,358.3,1073,0)
 ;;=C81.96^^19^113^226
 ;;^UTILITY(U,$J,358.3,1073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1073,1,3,0)
 ;;=3^Hodgkin Lymphoma,Intrapelvic Nodes,Unspec
 ;;^UTILITY(U,$J,358.3,1073,1,4,0)
 ;;=4^C81.96
 ;;^UTILITY(U,$J,358.3,1073,2)
 ;;=^5001457
 ;;^UTILITY(U,$J,358.3,1074,0)
 ;;=C81.97^^19^113^232
 ;;^UTILITY(U,$J,358.3,1074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1074,1,3,0)
 ;;=3^Hodgkin Lymphoma,Spleen,Unspec
 ;;^UTILITY(U,$J,358.3,1074,1,4,0)
 ;;=4^C81.97
 ;;^UTILITY(U,$J,358.3,1074,2)
 ;;=^5001458
 ;;^UTILITY(U,$J,358.3,1075,0)
 ;;=C81.98^^19^113^230
 ;;^UTILITY(U,$J,358.3,1075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1075,1,3,0)
 ;;=3^Hodgkin Lymphoma,Mult Site Nodes,Unspec
 ;;^UTILITY(U,$J,358.3,1075,1,4,0)
 ;;=4^C81.98
 ;;^UTILITY(U,$J,358.3,1075,2)
 ;;=^5001459
 ;;^UTILITY(U,$J,358.3,1076,0)
 ;;=C81.99^^19^113^218
 ;;^UTILITY(U,$J,358.3,1076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1076,1,3,0)
 ;;=3^Hodgkin Lymphoma,Extranodal/Solid Organ Sites,Unspec
 ;;^UTILITY(U,$J,358.3,1076,1,4,0)
 ;;=4^C81.99
 ;;^UTILITY(U,$J,358.3,1076,2)
 ;;=^5001460
 ;;^UTILITY(U,$J,358.3,1077,0)
 ;;=C82.00^^19^113^149
 ;;^UTILITY(U,$J,358.3,1077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1077,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Unspec Site
 ;;^UTILITY(U,$J,358.3,1077,1,4,0)
 ;;=4^C82.00
 ;;^UTILITY(U,$J,358.3,1077,2)
 ;;=^5001461
 ;;^UTILITY(U,$J,358.3,1078,0)
 ;;=C82.01^^19^113^142
 ;;^UTILITY(U,$J,358.3,1078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1078,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,1078,1,4,0)
 ;;=4^C82.01
 ;;^UTILITY(U,$J,358.3,1078,2)
 ;;=^5001462
 ;;^UTILITY(U,$J,358.3,1079,0)
 ;;=C82.02^^19^113^146
 ;;^UTILITY(U,$J,358.3,1079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1079,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,1079,1,4,0)
 ;;=4^C82.02
 ;;^UTILITY(U,$J,358.3,1079,2)
 ;;=^5001463
 ;;^UTILITY(U,$J,358.3,1080,0)
 ;;=C82.03^^19^113^144
 ;;^UTILITY(U,$J,358.3,1080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1080,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,1080,1,4,0)
 ;;=4^C82.03
 ;;^UTILITY(U,$J,358.3,1080,2)
 ;;=^5001464
 ;;^UTILITY(U,$J,358.3,1081,0)
 ;;=C82.04^^19^113^140
 ;;^UTILITY(U,$J,358.3,1081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1081,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,1081,1,4,0)
 ;;=4^C82.04
 ;;^UTILITY(U,$J,358.3,1081,2)
 ;;=^5001465
 ;;^UTILITY(U,$J,358.3,1082,0)
 ;;=C82.05^^19^113^143
 ;;^UTILITY(U,$J,358.3,1082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1082,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,1082,1,4,0)
 ;;=4^C82.05
 ;;^UTILITY(U,$J,358.3,1082,2)
 ;;=^5001466
 ;;^UTILITY(U,$J,358.3,1083,0)
 ;;=C82.06^^19^113^145
 ;;^UTILITY(U,$J,358.3,1083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1083,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,1083,1,4,0)
 ;;=4^C82.06
 ;;^UTILITY(U,$J,358.3,1083,2)
 ;;=^5001467
 ;;^UTILITY(U,$J,358.3,1084,0)
 ;;=C82.07^^19^113^148
 ;;^UTILITY(U,$J,358.3,1084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1084,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Spleen
 ;;^UTILITY(U,$J,358.3,1084,1,4,0)
 ;;=4^C82.07
 ;;^UTILITY(U,$J,358.3,1084,2)
 ;;=^5001468
 ;;^UTILITY(U,$J,358.3,1085,0)
 ;;=C82.08^^19^113^147
 ;;^UTILITY(U,$J,358.3,1085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1085,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,1085,1,4,0)
 ;;=4^C82.08
 ;;^UTILITY(U,$J,358.3,1085,2)
 ;;=^5001469
 ;;^UTILITY(U,$J,358.3,1086,0)
 ;;=C82.09^^19^113^141
 ;;^UTILITY(U,$J,358.3,1086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1086,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,1086,1,4,0)
 ;;=4^C82.09
 ;;^UTILITY(U,$J,358.3,1086,2)
 ;;=^5001470
 ;;^UTILITY(U,$J,358.3,1087,0)
 ;;=C82.10^^19^113^159
 ;;^UTILITY(U,$J,358.3,1087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1087,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Unspec Site
 ;;^UTILITY(U,$J,358.3,1087,1,4,0)
 ;;=4^C82.10
 ;;^UTILITY(U,$J,358.3,1087,2)
 ;;=^5001471
 ;;^UTILITY(U,$J,358.3,1088,0)
 ;;=C82.11^^19^113^152
 ;;^UTILITY(U,$J,358.3,1088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1088,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Head/Face/Neck
 ;;^UTILITY(U,$J,358.3,1088,1,4,0)
 ;;=4^C82.11
 ;;^UTILITY(U,$J,358.3,1088,2)
 ;;=^5001472
 ;;^UTILITY(U,$J,358.3,1089,0)
 ;;=C82.12^^19^113^156
 ;;^UTILITY(U,$J,358.3,1089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1089,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,1089,1,4,0)
 ;;=4^C82.12
 ;;^UTILITY(U,$J,358.3,1089,2)
 ;;=^5001473
 ;;^UTILITY(U,$J,358.3,1090,0)
 ;;=C82.13^^19^113^154
 ;;^UTILITY(U,$J,358.3,1090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1090,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,1090,1,4,0)
 ;;=4^C82.13
 ;;^UTILITY(U,$J,358.3,1090,2)
 ;;=^5001474
 ;;^UTILITY(U,$J,358.3,1091,0)
 ;;=C82.14^^19^113^150
 ;;^UTILITY(U,$J,358.3,1091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1091,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,1091,1,4,0)
 ;;=4^C82.14
 ;;^UTILITY(U,$J,358.3,1091,2)
 ;;=^5001475
 ;;^UTILITY(U,$J,358.3,1092,0)
 ;;=C82.15^^19^113^153
 ;;^UTILITY(U,$J,358.3,1092,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1092,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,1092,1,4,0)
 ;;=4^C82.15
 ;;^UTILITY(U,$J,358.3,1092,2)
 ;;=^5001476
 ;;^UTILITY(U,$J,358.3,1093,0)
 ;;=C82.16^^19^113^155
 ;;^UTILITY(U,$J,358.3,1093,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1093,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,1093,1,4,0)
 ;;=4^C82.16
 ;;^UTILITY(U,$J,358.3,1093,2)
 ;;=^5001477
 ;;^UTILITY(U,$J,358.3,1094,0)
 ;;=C82.17^^19^113^158
 ;;^UTILITY(U,$J,358.3,1094,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1094,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Spleen
 ;;^UTILITY(U,$J,358.3,1094,1,4,0)
 ;;=4^C82.17
 ;;^UTILITY(U,$J,358.3,1094,2)
 ;;=^5001478
 ;;^UTILITY(U,$J,358.3,1095,0)
 ;;=C82.18^^19^113^157
 ;;^UTILITY(U,$J,358.3,1095,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1095,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,1095,1,4,0)
 ;;=4^C82.18
 ;;^UTILITY(U,$J,358.3,1095,2)
 ;;=^5001479
 ;;^UTILITY(U,$J,358.3,1096,0)
 ;;=C82.19^^19^113^151
 ;;^UTILITY(U,$J,358.3,1096,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1096,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,1096,1,4,0)
 ;;=4^C82.19
 ;;^UTILITY(U,$J,358.3,1096,2)
 ;;=^5001480
 ;;^UTILITY(U,$J,358.3,1097,0)
 ;;=C82.20^^19^113^169
 ;;^UTILITY(U,$J,358.3,1097,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1097,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Uspec Site
 ;;^UTILITY(U,$J,358.3,1097,1,4,0)
 ;;=4^C82.20
 ;;^UTILITY(U,$J,358.3,1097,2)
 ;;=^5001481
 ;;^UTILITY(U,$J,358.3,1098,0)
 ;;=C82.21^^19^113^162
 ;;^UTILITY(U,$J,358.3,1098,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1098,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,1098,1,4,0)
 ;;=4^C82.21
 ;;^UTILITY(U,$J,358.3,1098,2)
 ;;=^5001482
 ;;^UTILITY(U,$J,358.3,1099,0)
 ;;=C82.23^^19^113^164
 ;;^UTILITY(U,$J,358.3,1099,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1099,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,1099,1,4,0)
 ;;=4^C82.23
 ;;^UTILITY(U,$J,358.3,1099,2)
 ;;=^5001484
 ;;^UTILITY(U,$J,358.3,1100,0)
 ;;=C82.22^^19^113^166
 ;;^UTILITY(U,$J,358.3,1100,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1100,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,1100,1,4,0)
 ;;=4^C82.22
 ;;^UTILITY(U,$J,358.3,1100,2)
 ;;=^5001483
 ;;^UTILITY(U,$J,358.3,1101,0)
 ;;=C82.24^^19^113^160
 ;;^UTILITY(U,$J,358.3,1101,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1101,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,1101,1,4,0)
 ;;=4^C82.24
 ;;^UTILITY(U,$J,358.3,1101,2)
 ;;=^5001485
 ;;^UTILITY(U,$J,358.3,1102,0)
 ;;=C82.25^^19^113^163
 ;;^UTILITY(U,$J,358.3,1102,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1102,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,1102,1,4,0)
 ;;=4^C82.25
 ;;^UTILITY(U,$J,358.3,1102,2)
 ;;=^5001486
 ;;^UTILITY(U,$J,358.3,1103,0)
 ;;=C82.26^^19^113^165
 ;;^UTILITY(U,$J,358.3,1103,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1103,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,1103,1,4,0)
 ;;=4^C82.26
 ;;^UTILITY(U,$J,358.3,1103,2)
 ;;=^5001487
 ;;^UTILITY(U,$J,358.3,1104,0)
 ;;=C82.27^^19^113^168
 ;;^UTILITY(U,$J,358.3,1104,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,1104,1,3,0)
 ;;=3^Follicular Lymphoma Grade III,Spleen
 ;;^UTILITY(U,$J,358.3,1104,1,4,0)
 ;;=4^C82.27
 ;;^UTILITY(U,$J,358.3,1104,2)
 ;;=^5001488
 ;;^UTILITY(U,$J,358.3,1105,0)
 ;;=C82.28^^19^113^167